Investors
Thomas Meier
Chief Executive Officer, CEO
Born: 1968
Nationality: Swiss
First appointed: February 1, 2026
Term of office: January 31, 2029
Thomas Meier studied chemistry at the Zurich University of Applied Sciences and holds a degree as a chemist. In addition, he obtained a degree as an industrial engineer (STA - Swiss Technical Association) and completed the Advanced Management Programme at the INSEAD Business School in Fontainebleau/Paris.
Starting in 2020, he served as CEO of Bachem Holding AG, a Swiss CDMO (Contract Development and Manufacturing Organization) listed on the SIX Swiss Exchange. Prior to that, Thomas Meier served as Chief Operations Officer in Bachem’s executive management and worked as Head of Manufacturing at Peninsula Laboratories in San Carlos, California, USA from 2001 to 2004. Over the course of his career, he held various leadership positions at Bachem for more than 30 years.
Thomas Meier has extensive and well-founded experience in corporate leadership and business transformation as well as broad expertise in financial transactions.
External mandates:
Thomas Meier currently serves on the Board of Directors of Viollier AG, Switzerland.
Receive e-mail updates on the latest news and the publication of financial reports. This will automatically keep you up to date.
Registration is free of charge and can be revoked at any time.
Claudia Nickolaus
Head of Investor & Public Relations ESG Communications
+49 30 232 566 800
ir@medios.group
We have been informed of a fake listing of a cosmetic product on the TEMU platform in which Medios is falsely named as the distributor. Unfortunately, such unauthorized product listings are repeatedly observed on unreliable platforms like TEMU.
We would like to clarify: This offer is in no way connected to Medios and is not authorized. Our legal department has been informed.
Please obtain medical products exclusively through authorized and verified sources.
If you have any further questions, please contact: ir@medios.group
